SCHEMBL31398135

SCHEMBL31398135

Cn1cnc(-c2ccc(NC(=O)OC(C)(C)C)cc2)n1

nearest known ligand 0.51

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ CYP17A1 P05093 3/20 0.51
▸ GPR119 Q8TDV5 1/20 0.50
▸ PSMB8 P28062 1/20 0.48
▸ MAP4K4 O95819 1/20 0.47
▸ CD274 Q9NZQ7 1/20 0.46
▸ NAMPT P43490 1/20 0.45
▸ MAPK14 Q16539 1/20 0.45
▸ MTOR P42345 1/20 0.44
▸ PRKDC P78527 1/20 0.43
▸ BCL2 P10415 4/20 0.43
▸ BECN1 Q14457 4/20 0.43
▸ TTK P33981 1/20 0.42
▸ GSK3B P49841 1/20 0.42
▸ DYRK1A Q13627 1/20 0.42
▸ PTGDR2 Q9Y5Y4 1/20 0.42
▸ MAPKAPK2 P49137 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16073030 0.81 CYP17A1 (0.46) CYP17A1PSMB8MAP4K4CD274NAMPT
SCHEMBL23840613 0.79 NAMPT (0.47) GPR119NAMPT
SCHEMBL20865536 0.78 CYP17A1 (0.68) CYP17A1PSMB8MAP4K4CD274NAMPT
SCHEMBL11942673 0.77 TRPV1 (0.43) CYP17A1GPR119PSMB8
SCHEMBL13055402 0.76 CYP17A1 (0.59) CYP17A1PSMB8MAP4K4NAMPTMAPK14
SCHEMBL14087508 0.76 GSK3B (0.40) CYP17A1GPR119PSMB8MAP4K4NAMPT
SCHEMBL26328838 0.75 CYP17A1 (0.55) CYP17A1PSMB8MAP4K4CD274NAMPT
SCHEMBL26328883 0.75 CYP17A1 (0.55) CYP17A1PSMB8MAP4K4CD274NAMPT
SCHEMBL11029675 0.75 P2RY14 (0.42) CYP17A1PSMB8MAP4K4CD274NAMPT
SCHEMBL6819178 0.74 NAMPT (0.57) CYP17A1PSMB8CD274NAMPTGSK3B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024262911-A1 NOVEL PYRAZOLO PYRIMIDINE-BASED COMPOUND AND USE THEREOF 주식회사 에이조스바이오 2024-12-26 — — WO disclosed
Send feedback